مرضى Allurion | Review Programme and Download App

Choose your country or region in order to display more relevant content.

Select

Other country or region

Country

Language

التالي

معلومات المريض

سواء كنت بانتظار تركيب البالون قريباً، أو كنت حالياً في وسط البرنامج الذي مدته 16 أسبوعاً، فنحن هنا لمساعدتك خلال رحلتك.

ما الذي تتوقعه

اعرف ماذا يجب ان تتوقع في كل خطوة في رحلتك لإنقاص الوزن

الأسئلة الشائعة

احصل على إجابات من خبرائنا في عالم التخسيس

صفحة المرضى

احصل على بياناتك وإحصائياتك من على بوابتك الإلكترونية

البدء باستخدام أجهزتك

كيفية يمكنك إعداد ميزانك الذكي وجهاز تتبع الحالة الصحية

Una ragazza che si gode i risultati della perdita di peso dopo l'uso del pallone gastrico

انضم إلى مجتمعنا

سجّل دخولك إلى صفحة المريض اليوم لمتابعة تقدمك

انضم الآن

La bilancia e l'orologio Allurion Health Tracker e l'applicazione mobile Allurion.

الدعم الفني لأجهزة ألوريون

قم بتحميل مواردنا المجانية لميزانك الذكي وأداة تتبع الحالة الصحية وتطبيق الجوال

تحميل

Applicazione mobile Allurion

Apple Health

إعداد تطبیق Apple Health في تطبیق Allurion لنظام تشغیل iOS

Apple Health

*As with any medical solution, results may vary from one patient to another, and some patients may not respond to treatment. Please consult a doctor to carefully evaluate the risks and benefits before making your decision.
**The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical intervention. In rare cases, instead of being expelled through the digestive tract, the empty balloon may be vomited out.
***Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a careful review of your medical history. In the case of an extended Allurion Program, your eligibility is reassessed before each placement to ensure you continue to meet the required conditions.

R. Ienca et al. The procedureless ellipse gastric balloon program: Multicenter experience in 1770 consecutive patients. Obes surg. 2020;30(9):3354-3362. Multicenter, prospective, non-randomized, open registry study conducted in patients with overweight or obesity from January 2016 to June 2019 in 19 international obesity centers participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m2 at baseline underwent treatment with the Elipse swallowable gastric balloon, with a monthly visit and a total follow-up of 4 months. 63 patients (3.6%) did not complete the program, and the balloon was removed before 4 months due to intolerance or other adverse effects.
World Health Organization – Key facts on Obesity and overweight (who.int).
European survey finds over three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful – EASO.
This information is extracted from the instructions for use of the Allurion Gastric Balloon System. Version number CS137-02-ENG. If you have any questions regarding this document, please consult your doctor.

Chat with Ally